HMGB1 and cancer: We have shown that paclitaxel, an anti-cancer drug, directly causes ROS accumulation and activation of p38MAPK and NF-κB in macrophages, which causes HAT upregulation followed by cytoplasmic translocation and extracellular release of HMGB1 [8].